Ricardo Mancebo is the founder and CEO of GenEndeavor, a pioneering molecular diagnostics technology company focused on early and rapid disease detection and cost-effective trait screening. He founded GenEndeavor to develop a new generation of non-enzymatic assay technology platforms to break existing diagnostic barriers. Ricardo has spent more than 20 years developing cutting-edge genomics technologies and products in the biotech industry. His mission is to save lives and feed more people through very early screening of genetic disease biomarkers, rapid identification of infectious disease pathogens, and cost-effective genetic screening of agricultural traits in plant breeding programs. Dr. Mancebo received his Ph.D., M.Phil., and M.A. in Biological Sciences from Columbia University. Dr. Mancebo initiated his postdoctoral research at Yale University, Howard Hughes Medical Institute, and completed his postdoctoral training at Stanford University.